Perspective Therapeutics, Inc.
CATX
$1.92
-$0.02-1.03%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -70.46% | -154.12% | -213.73% | -497.11% | -332.23% |
| Total Depreciation and Amortization | 321.29% | 93.47% | 91.25% | 99.31% | 123.13% |
| Total Amortization of Deferred Charges | 0.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 325.72% | 341.85% | 321.89% | 293.15% | 481.84% |
| Change in Net Operating Assets | 1,141.82% | 3,314.34% | 2,667.92% | 2,514.88% | 343.90% |
| Cash from Operations | 50.44% | 97.84% | 40.66% | 28.65% | -254.90% |
| Capital Expenditure | -4,975.93% | -3,720.79% | -1,046.97% | -2,075.71% | -280.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -100.00% | -100.00% | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -824.75% | -239.11% | -581.67% | -543.60% | 179.24% |
| Cash from Investing | -998.25% | -361.19% | -1,126.70% | -1,202.32% | 184.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 29.41% | 14.29% | -51.43% | -333.33% | -- |
| Issuance of Common Stock | 31,389.76% | 52,145.49% | 51,474.64% | 597,250.00% | 3,178.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 443,261.54% | 100.00% | 100.00% | 100.00% | -- |
| Cash from Financing | 36,764.33% | 66,734.18% | 62,675.00% | 321,625.00% | 2,703.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 543.73% | 20,803.58% | 911.31% | 570.63% | 70.14% |